File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: A longitudinal study on quality of life after gynecologic cancer treatment

TitleA longitudinal study on quality of life after gynecologic cancer treatment
Authors
KeywordsGynecologic oncology
Longitudinal
Quality of life
Issue Date2001
PublisherAcademic Press. The Journal's web site is located at http://www.elsevier.com/locate/ygyno
Citation
Gynecologic Oncology, 2001, v. 83 n. 1, p. 10-19 How to Cite?
AbstractObjective. The objective was to describe the pattern of quality of life (QOL) over time and to assess the impact of age, symptoms, disease parameters, and treatment on the overall QOL. Methods. A longitudinal study on patients with newly diagnosed gynecologic cancer using individual patients as their own control was performed. The 33-item EORTC QLQ-C30(+3) was used as the QOL measure. Patients were assessed before treatment, after completion of treatment, and at 6, 12, and 24 months. Spearman's correlation analyses were performed. A mixed effect model was fitted to the data. Bonferroni pairwise comparisons were used to analyze the different variables. Results. One hundred forty-four women completed the study. Overall QOL improved after the completion of treatment but remained the same throughout the 2 years after treatment. The individual patient's QOL before treatment was insignificant while the impact of treatment on the individual patient was significant in determining QOL after treatment. There was a strong correlation for all time points in most factors, indicating that the global health status, functional scales, and symptom scales exhibit a dependent change over time. Relief in symptoms was associated with improvements in functional scales. The scores on overall QOL were lower for younger patients and for patients treated with chemotherapy than for patients treated with surgery. Conclusions. Strategies for supportive care need to focus on symptom management. Psychosocial interventions, to be effective, should include all patients and should aim to reduce the impact of treatment on the individual patient. © 2001 Academic Press.
Persistent Identifierhttp://hdl.handle.net/10722/87229
ISSN
2015 Impact Factor: 4.198
2015 SCImago Journal Rankings: 2.284
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorChan, YMen_HK
dc.contributor.authorNgan, HYSen_HK
dc.contributor.authorLi, BYGen_HK
dc.contributor.authorYip, AMWen_HK
dc.contributor.authorNg, TYen_HK
dc.contributor.authorLee, PWHen_HK
dc.contributor.authorYip, PSFen_HK
dc.contributor.authorWong, LCen_HK
dc.date.accessioned2010-09-06T09:27:00Z-
dc.date.available2010-09-06T09:27:00Z-
dc.date.issued2001en_HK
dc.identifier.citationGynecologic Oncology, 2001, v. 83 n. 1, p. 10-19en_HK
dc.identifier.issn0090-8258en_HK
dc.identifier.urihttp://hdl.handle.net/10722/87229-
dc.description.abstractObjective. The objective was to describe the pattern of quality of life (QOL) over time and to assess the impact of age, symptoms, disease parameters, and treatment on the overall QOL. Methods. A longitudinal study on patients with newly diagnosed gynecologic cancer using individual patients as their own control was performed. The 33-item EORTC QLQ-C30(+3) was used as the QOL measure. Patients were assessed before treatment, after completion of treatment, and at 6, 12, and 24 months. Spearman's correlation analyses were performed. A mixed effect model was fitted to the data. Bonferroni pairwise comparisons were used to analyze the different variables. Results. One hundred forty-four women completed the study. Overall QOL improved after the completion of treatment but remained the same throughout the 2 years after treatment. The individual patient's QOL before treatment was insignificant while the impact of treatment on the individual patient was significant in determining QOL after treatment. There was a strong correlation for all time points in most factors, indicating that the global health status, functional scales, and symptom scales exhibit a dependent change over time. Relief in symptoms was associated with improvements in functional scales. The scores on overall QOL were lower for younger patients and for patients treated with chemotherapy than for patients treated with surgery. Conclusions. Strategies for supportive care need to focus on symptom management. Psychosocial interventions, to be effective, should include all patients and should aim to reduce the impact of treatment on the individual patient. © 2001 Academic Press.en_HK
dc.languageengen_HK
dc.publisherAcademic Press. The Journal's web site is located at http://www.elsevier.com/locate/ygynoen_HK
dc.relation.ispartofGynecologic Oncologyen_HK
dc.subjectGynecologic oncologyen_HK
dc.subjectLongitudinalen_HK
dc.subjectQuality of lifeen_HK
dc.titleA longitudinal study on quality of life after gynecologic cancer treatmenten_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0090-8258&volume=83&spage=10&epage=19&date=2001&atitle=A+longitudinal+study+on+quality+of+life+after+gynecologic+cancer+treatmenten_HK
dc.identifier.emailNgan, HYS: hysngan@hkucc.hku.hken_HK
dc.identifier.emailYip, PSF: sfpyip@hku.hken_HK
dc.identifier.authorityNgan, HYS=rp00346en_HK
dc.identifier.authorityYip, PSF=rp00596en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1006/gyno.2001.6345en_HK
dc.identifier.pmid11585408-
dc.identifier.scopuseid_2-s2.0-0034785828en_HK
dc.identifier.hkuros65374en_HK
dc.identifier.hkuros131454-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0034785828&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume83en_HK
dc.identifier.issue1en_HK
dc.identifier.spage10en_HK
dc.identifier.epage19en_HK
dc.identifier.isiWOS:000171555900003-
dc.publisher.placeUnited Statesen_HK
dc.identifier.scopusauthoridChan, YM=7403676661en_HK
dc.identifier.scopusauthoridNgan, HYS=34571944100en_HK
dc.identifier.scopusauthoridLi, BYG=15767862000en_HK
dc.identifier.scopusauthoridYip, AMW=19838748300en_HK
dc.identifier.scopusauthoridNg, TY=7402229853en_HK
dc.identifier.scopusauthoridLee, PWH=7406120357en_HK
dc.identifier.scopusauthoridYip, PSF=7102503720en_HK
dc.identifier.scopusauthoridWong, LC=7402092003en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats